Overexpression of transforming growth factor β1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation

Cancer Research

Volumn 64, Issue 13, 2004, Pages 4405-4410

  Lu, Shi Long ^a   Reh, Douglas ^a   Li, Allen G ^a   Woods, Jennifer ^a   Corless, Christopher L ^a   Kulesz Martin, Molly ^a,b   Wang, Xiao Jing ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; GENE EXPRESSION; HEAD; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INFLAMMATION; MICROENVIRONMENT; MOUSE; NECK; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STROMA; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HEAD AND NECK NEOPLASMS; HUMANS; HYPERPLASIA; INFLAMMATION; MICE; MICE, TRANSGENIC; MOUTH; MOUTH MUCOSA; NEOVASCULARIZATION, PATHOLOGIC; OROPHARYNX; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 3042778716     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1032     Document Type: Article

References (20)

1. Neville BW, Day TA. Oral cancer and precancerous lesions. CA - Cancer J Clin 2002;52:195-215.
2. Reiss M. TGF-beta and cancer. Microbes Infect 1999;1:1327-47.
3. Fukai Y, Fukuchi M, Masuda N, et al. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer 2003;104:161-6.
4. Logullo AF, Nonogaki S, Miguel RE, et al. Transforming growth factor beta1 (TGF-beta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J Oral Pathol Med 2003;32:139-45.
5. Weeks BH, He W, Olson KL, Wang XJ. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Cancer Res 2001;61:7435-43.
6. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 2001;187:265-76.
7. Goumans MJ, Valdimarsdottir G, Itoh S, et al. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002;21:1743-53.
8. Wang XJ, Liefer KM, Tsai S, O'Malley BW, Roop DR. Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci USA 1999;96:8483-8.
9. Li AG, Wang D, Feng XH, Wang XJ. Latent TGF-beta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 2004;23:1770-81.
10. Cao T, He W, Roop DR, Wang XJ. K14-GLp65 transactivator induces transgene expression in embryonic epidermis. Genesis 2002;32:189-90.
11. He W, Li AG, Wang D, et al. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J 2002;21:2580-90.
12. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 1994;91:8180-4.
13. Wakefield LM, Winokur TS, Hollands RS, et al. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Investig 1990;86:1976-84.
14. Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003;12:817-28.
15. Gleich LL, Salamone FN. Molecular genetics of head and neck cancer. Cancer Control 2002;9:369-78.
16. Wahl SM. TGF-beta in the evolution and resolution of inflammatory and immune processes. Introduction. Microbes Infect 1999;1:1247-9.
17. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
18. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Investig 2001;107:7-11.
19. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003;100:2645-50.
20. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999;38:241-51.